Back
Cognition Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
CGTX
Cognition Therapeutics
Last Price:
$0.32
Seasonality Move:
-16.41%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cognition Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Sell |
20-day SMA: | 0.39 | Sell |
50-day SMA: | 0.4 | Sell |
200-day SMA: | 0.54 | Sell |
8-day EMA: | 0.35 | Sell |
20-day EMA: | 0.37 | Sell |
50-day EMA: | 0.42 | Sell |
200-day EMA: | 0.69 | Sell |
Cognition Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 39.87 | Sell |
Chaikin Money Flow: | 819214 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.33 - 0.43) | Sell |
Bollinger Bands (100): | (0.38 - 0.68) | Sell |
Cognition Therapeutics Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.33 while CGTX 8-day simple moving average is 0.35, which is a Sell signal.
-
The stock price of CGTX is 0.33 while Cognition Therapeutics 20-day SMA is 0.39, which makes it a Sell.
-
Cognition Therapeutics 50-day simple moving average is 0.40 while CGTX share price is 0.33, making it a Sell technically.
-
CGTX stock price is 0.33 and Cognition Therapeutics 200-day simple moving average is 0.54, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
27
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.33. The Score for CGTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
20.7M
Price in USD:
0.33
Share Volume:
819.2K
Cognition Therapeutics 52-Week Range
52-Week High:
2.95
52-Week Low:
0.28
Sell
27
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.33 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.33 while CGTX 8-day exponential moving average is 0.35, which is a Sell signal.
-
The stock price of CGTX is 0.33 while Cognition Therapeutics 20-day EMA is 0.37, which makes it a Sell.
-
Cognition Therapeutics 50-day exponential moving average is 0.42 while CGTX share price is 0.33, making it a Sell technically.
-
CGTX stock price is 0.33 and Cognition Therapeutics 200-day simple moving average is 0.69, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.04 per share, an increase this year of $0.36 per share, and an increase next year of $0.12 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 39.87, which suggest Cognition Therapeutics is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.33 - 0.43), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.38 - 0.68), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.